Wessam Sonbol, CSM, CSPO, ICP-ACC’s Post

Dear LinkedIn Community, I'm thrilled to invite you all to an upcoming event that promises to be both informative and engaging! Whether you're from academic, an aspiring entrepreneur, or someone looking to expand your network, this event is for you. Biotech Innovation Funding Networking in LA. 📅 Date: April 6th, 2024 ⏰ Time: 1:00-5:00 pm 📍 ☀️ ScaleHealth 3415 S Sepulveda Blvd FL 10 Los Angeles, CA 90034 Join us! ➡️ https://lnkd.in/euDuGG4m This highly anticipated event will serve as a gathering ground for biotech leaders, founders, and investors, all with the shared objective of identifying the next billion-dollar unicorn. Our aim is not only to connect and unite the biotech ecosystem in the USA but also to foster collaboration and drive advancements in the APAC region, collectively shaping the future of the life science industry. As a testament to their outstanding achievements, each winner will be granted the privilege of being featured on the prestigious GeneOnline and TiBIA platforms. This exposure will provide them with valuable visibility and recognition within the industry. Additionally, the winners will be presented with a special prize, further acknowledging their remarkable contributions and accomplishments. Registration here. Biotech Innovation Funding Networking Tickets, Sat, Apr 6, 2024 at 1:00 PM Why Should You Attend? 1️⃣ Networking: Connect with like-minded individuals, potential collaborators, and industry experts. 2️⃣ Knowledge Sharing: Gain valuable insights and learn from seasoned professionals in your field. 3️⃣ Inspiration: Get inspired by success stories, innovative ideas, and impactful strategies. 4️⃣ Opportunity: Discover new opportunities, partnerships, and pathways to success. This event is open to all professionals, entrepreneurs, students, and anyone interested in learning and growing. Don't miss this chance to expand your horizons, connect with peers, and fuel your success journey. RSVP today to secure your spot and mark your calendar! Let's come together, share our experiences, and inspire each other to reach new heights. Feel free to tag friends, colleagues, and anyone who might benefit from this event. Let's make it a vibrant and enriching gathering! See you there!

A lab without Labguru? It wasn't an option for Dr. Alon Silberman, MitoCareX Bio Co-Founder and Chief Scientific Officer. MitoCareX Bio is a successful early-stage drug discovery startup. They've been using Labguru since day 1. With us, they have: ⏱️ Saved 3+ hours every week 💰 Saved $300/month thanks to effective inventory management 🧪 Simplified experiment planning & improved consistency of results 🗃️ Made lab data centralized, searchable, and traceable We interviewed Dr. Alon Silberman, MitoCareX Bio Co-Founder and Chief Scientific Officer, to discover why he couldn't imagine lab life without Labguru. This is what he said 👇 📌Full Case study: https://bit.ly/4dEDQfn

Calling all early stage biotech founders... Whether you are still at concept/ idea phase or already launched your early stage fundraising, Black Swann Consulting Group would love to help you on your journey. With experience in both scientific, business and fundraising plans and strategies, we'd love to help make your early stage biotech a success. We only win, if you win! Success based fee so we take the risk with you and share the conviction with you! Let's talk! #Biotech #GoToMarket #ProductMarketFit #FounderMarketFit #DrugDiscovery #CommercialLifeScience #LifeScience #BiotechPlatform #TechBio

🚀 Showcase Alert! September 12 at 11:30AM, Tezcat Biosciences will be presenting at LSX World Congress on the Biotech Stage! 🚀 Craig Ramirez, Ph.D. will be discussing Tezcat’s cutting-edge receptor-independent drug delivery technology, specifically targeting mutant RAS solid tumors and myeloma. Tezcat’s lead asset, TZT-102, is a revolutionary protein-drug conjugate with a novel mechanism of action. Unlike traditional therapies, TZT-102 tackles mutant RAS cancers by addressing the metabolic and phenotypic effects of mutant RAS signaling, offering a broader impact across all RAS cancers. It's designed to be resistant to drug resistance and boasts a superior therapeutic index compared to FDA-approved antibody-drug conjugates. This breakthrough offers new hope for adult patients facing these challenging conditions. Don’t miss this opportunity to learn about Tezcat's game-changing innovations in oncology! #LSXWorldCongress #PrecisionMedicine #Oncology #Biotech #DrugDevelopment #LSXUSA

Launching a biotech is challenging but the right partners can help you overcome major barriers and reach value inflection points. Pick the best partners who take the journey with you! Black Swann Consulting Group

What a successful #TechBioUK event hosted by the BioIndustry Association (BIA)! 🙌 I attended for the first time this year and it was truly a remarkable experience. Kudos to BIA for delivering yet another exceptional event! 🥂 It was insightful to hear opinions from Directors, VPs and CEOs on the distinctions between Techbios and Biotechs: after 10 years of the growing TechBio industry, it's still not clearly defined! One thing is certain, Techbios are changing the trajectory of drug discover and in the Life Science Industry, 🔬 new businesses will have to consider how to apply tech to science more and more to improve probability of industrialising products in the future. 🧪🎇

One company optimizing protein conjugates, one company screening for optimal efficacy and therapeutic window of protein conjugates. Well played, #RESIBoston2024 #ADCs #startup #proteinconjugation

Early bird rates end June 3 for BioCentury Grand Rounds – an R&D conference in Nashville for academic innovators, researchers, investors and industry leaders to explore the translational science behind the next wave of biotech breakthroughs and the people driving them. Take advantage of these special rates and make connections with peers across the biopharma sphere as we discuss: ➤ What Investors Want: Gain insights from top investors on what they’re looking for in today’s market.   ➤ New Investible Space: Discover emerging sectors and opportunities that are catching the eye of investors.   ➤ Measurements of Translational Success: Learn how to measure and showcase the impact of your innovations. Register now to secure your spot at #BioCenturyGrandRounds: https://loom.ly/yydzbC8 Submit your nominations to join the Presenting Companies Class of 2024 by June 3 to lock in early bird rates: https://loom.ly/GHHuDog #GrandRounds #BiotechBreakthroughs #researchdevelopment #academia #venturecapital #biotech #drugdiscovery #drugdevelopment #RnD

Download the poster today titled 'A high -throughput, in vitro assessment of antibiotic induced podocyte injury' https://lnkd.in/gyeBScNa

More interesting thoughts from Darwin Ling in the Bullpen Inning 1.